SEC Filing Details

Document Details

Filing Date
Jun 26, 2020
Document Date
Jun 26, 2020
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline